Support the Islet Cell Act for Type 1 diabetes

Recent signers:
Ram Rajagopalan and 19 others have signed recently.

The Issue

As a Type 1 diabetic, I have experienced firsthand the challenges and struggles associated with managing this lifelong disease. It is not just a personal journey, but one that countless others, especially children, embark on every day. The Islet Cell Act represents a beacon of hope for us all. This act has the potential to transform the management of Type 1 diabetes, offering a chance at a more normal life by recognizing islet cell transplants as a standard practice, akin to organ transplants.

At its core, the Islet Cell Act calls for insurance companies to recognize and cover islet cell transplants, which have shown promising results in scientific trials. The remarkable advancements in this field mean that islet cell transplants could effectively change how we view and treat Type 1 diabetes. Current science supports the efficacy and safety of these procedures, and it's time that insurance policies reflect this reality.

Imagine a world where children born into a life of blood sugar monitoring and insulin dependence could instead look forward to a life of freedom from these constraints. The cost savings in long-term diabetes management, reduced need for ongoing medical interventions, and improved quality of life are enormous.

Insurance companies have a pivotal role to play in realizing this vision. By treating these transplants as they would a kidney or heart transplant, they can alleviate much of the financial burden placed on families affected by Type 1 diabetes. In countries such as Canada and parts of Europe, steps have already been taken to integrate islet cell transplants into their healthcare systems, demonstrating both the feasibility and effectiveness of this approach.

The time has come for the United States to take a stand and embrace these life-altering advancements in medical science. We owe it to current and future generations to ensure that they have access to the best possible care. Join me in advocating for the Islet Cell Act and make a tangible difference in the lives of those suffering from Type 1 diabetes.

Please sign the petition to urge legislators and insurance companies to support the Islet Cell Act, and change so many lives for the better, especially our children. Together, we can push for a future where Type 1 diabetes doesn't have to define our lives or limit our potential.

177

Recent signers:
Ram Rajagopalan and 19 others have signed recently.

The Issue

As a Type 1 diabetic, I have experienced firsthand the challenges and struggles associated with managing this lifelong disease. It is not just a personal journey, but one that countless others, especially children, embark on every day. The Islet Cell Act represents a beacon of hope for us all. This act has the potential to transform the management of Type 1 diabetes, offering a chance at a more normal life by recognizing islet cell transplants as a standard practice, akin to organ transplants.

At its core, the Islet Cell Act calls for insurance companies to recognize and cover islet cell transplants, which have shown promising results in scientific trials. The remarkable advancements in this field mean that islet cell transplants could effectively change how we view and treat Type 1 diabetes. Current science supports the efficacy and safety of these procedures, and it's time that insurance policies reflect this reality.

Imagine a world where children born into a life of blood sugar monitoring and insulin dependence could instead look forward to a life of freedom from these constraints. The cost savings in long-term diabetes management, reduced need for ongoing medical interventions, and improved quality of life are enormous.

Insurance companies have a pivotal role to play in realizing this vision. By treating these transplants as they would a kidney or heart transplant, they can alleviate much of the financial burden placed on families affected by Type 1 diabetes. In countries such as Canada and parts of Europe, steps have already been taken to integrate islet cell transplants into their healthcare systems, demonstrating both the feasibility and effectiveness of this approach.

The time has come for the United States to take a stand and embrace these life-altering advancements in medical science. We owe it to current and future generations to ensure that they have access to the best possible care. Join me in advocating for the Islet Cell Act and make a tangible difference in the lives of those suffering from Type 1 diabetes.

Please sign the petition to urge legislators and insurance companies to support the Islet Cell Act, and change so many lives for the better, especially our children. Together, we can push for a future where Type 1 diabetes doesn't have to define our lives or limit our potential.

Supporter Voices

Petition updates